SCA
CELG

Snowden Capital Advisors’s Celgene Corp CELG Stock Holding History

Snowden Capital Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-2,290
Closed -$227K – 591
2019
Q3 		$227K Sell
2,290
-571
-20% -$54.3K 0.02% 480
2019
Q2 		$264K Sell
2,861
-254
-8% -$24.1K 0.03% 432
2019
Q1 		$294K Sell
3,115
-473
-13% -$41.4K 0.03% 411
2018
Q4 		$230K Buy
3,588
+495
+16% +$36.5K 0.03% 428
2018
Q3 		$277K Buy
+3,093
New +$273K 0.03% 402
2018
Q1 		– Sell
-2,164
Closed -$226K – 442
2017
Q4 		$226K Sell
2,164
-481
-18% -$54.3K 0.03% 373
2017
Q3 		$386K Buy
2,645
+343
+15% +$46.7K 0.06% 289
2017
Q2 		$299K Sell
2,302
-174
-7% -$21.3K 0.06% 285
2017
Q1 		$308K Buy
+2,476
New +$296K 0.07% 271

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Snowden Capital Advisors's CELG Position: Q4 2019 in Review

Snowden Capital Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,290 shares — an estimated $227K sold.

Snowden Capital Advisors first reported a position in CELG in Q1 2017 and held it in 9 quarters. The position peaked at $386K in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Snowden Capital Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Snowden Capital Advisors sold 2,290 Celgene Corp shares in Q4 2019, an estimated $227K.
  • Snowden Capital Advisors first reported a position in Celgene Corp in Q1 2017 and held it in 9 quarters.
  • Snowden Capital Advisors's Celgene Corp position peaked at $386K in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Snowden Capital Advisors's 13F filing for Q4 2019, filed 8 Jan 2024.